Though older Hispanic Americans are 1.5 times more likely to be diagnosed with Alzheimer's disease than older white Americans, it's a reality a San Jose woman says her community is often reluctant to accept.
Older Hispanic Americans face a one-and-a-half times greater likelihood of Alzheimer's disease diagnosis than their older white peers, numbers show.ABC7 News proudly sponsors A Walk to End Alzheimer's in two Bay Area communities, emphasizing the profound impacts of Alzheimer's disease. Alarmingly, older Hispanic Americans face a one-and-a-half times greater likelihood of a dementia diagnosis than their older white peers, according to the Alzheimer's Association.
"She had a favorite song. It was Angelos de mis Anhelos. That was her favorite song," Rosa said, adding, "I remember all the time she used to sing that song." Even when dementia began to obscure her memories, making her forget loved ones and past events, Maria clung to the lyrics of her favorite song.
Though older Hispanic Americans are 1.5 times more likely to be diagnosed with the disease than older white Americans, Rosa said it's a reality her community is often reluctant to accept."Sometimes, especially as the Latino community, we don't want to say that somebody has Alzheimer's. We'll just say 'Oh, they're forgetful,'" Rosa said.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Flu shots may protect against the risk of Alzheimer’s, related dementiasSome studies have shown that vaccinated individuals appear less likely than the unvaccinated to develop dementia, although scientists aren’t sure why.
Read more »
BioXcel Therapeutics shares pop after audit of Alzheimer's trial dataAudit findings support application for approval of treatment for Alzheimer’s-related agitation, company says
Read more »
Common Fungus Linked to Alzheimer's DiseaseA disturbing new study found that the common fungus Candida albicans (C. albicans) can enter the brain and trigger a cascade of events that may lead to Alzheimer's disease. Scientists from Baylor College of Medicine reveal that as the brain endeavors to clear the fungus,...
Read more »
Biogen and Eisai release new Alzheimer’s drug data that may support wider uptakeEisai plans to apply for FDA approval of subcutaneous Leqembi by early next year
Read more »
Alzheimer’s drug Leqembi could be given as shots rather than IV infusion, study suggestsThe Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the disease, may be able to be given as a set of two weekly shots at home, a study from drugmaker Eisai suggests, potentially providing a more convenient way for patients to get treatment.
Read more »